中国循证儿科杂志 ›› 2020, Vol. 15 ›› Issue (1): 50-54.

• 论著 • 上一篇    下一篇

NFKB1基因新位点突变导致EB病毒淋巴增殖疾病的 临床免疫和遗传特征

林丽1,2王莹1,2王文婕1刘璐瑶1孙金峤1王晓川1   

  1. 1 复旦大学附属儿科医院临床免疫科上海,201102;2 共同第一作者
  • 收稿日期:2019-12-30 修回日期:2020-01-21 出版日期:2020-02-25 发布日期:2020-03-16
  • 通讯作者: 孙金峤,王晓川
  • 基金资助:
     

The clinical, immunological and genetical features of Epstein-Barr virus lymphoproliferative diseases caused by a novel NFKB1 mutation

 LIN Li1,2, WANG Ying1,2, WANG Wen-jie1, LIU Lu-yao1, SUN Jin-qiao1, WANG Xiao-chuan1   

  1.  1 Department of Clinical Immunology, Children's Hospital of Fudan University, Shanghai 201102, China; 2 Co-first author
  • Received:2019-12-30 Revised:2020-01-21 Online:2020-02-25 Published:2020-03-16
  • Contact: SUN Jin-qiao,WANG Xiao-chuan
  • Supported by:
     

摘要: 目的:NFKB1缺陷可导致不同临床和免疫表型, EBV相关表型报道罕见,本文可扩展该病的疾病谱。方法:分析1例NFKB1缺陷患儿的临床症状和体征,进行常规免疫评估、淋巴细胞亚群精细分型、全外显子测序、Sanger测序、荧光定量PCR和蛋白免疫印迹等实验。结果:患儿12岁,女,反复发热6月,肝功能指标异常增高,出现凝血异常,肝功能受损、肝脾和淋巴结肿大等淋巴增殖表现。EBV载量异常升高,NK细胞明显增高。全外显子测序提示NFKB1 c.2430dupA, 属新发突变,且该突变位点未经报道。不同于之前文献的报道,此突变位于蛋白的死亡结构域,预测将导致氨基酸翻译提前终止,功能实验提示p50蛋白表达降低、NFKB1 mRNA稳定性被破坏。结论:结合临床、免疫和遗传表型,患儿NFKB1缺陷导致EBV淋巴增殖可确诊,丰富了NFKB1缺陷的临床和遗传表型。

 

Abstract: Abstract Objective:NFKB1 deficiency will result in a variety of clinical and immunological features. EpsteinBarr virusinduced disease is a rare phenotype. We report the case to expand the spectrum of this disease. Methods:We analyzed clinical manifestations and physical signs of one patient with NFKB1 deficiency and performed immunological evaluation, Lymphocyte subpopulation, Whole exome sequencing (WES), Sanger sequencing, Realtime PCR and Western blot. Results:The patient is a 12year-old female. She suffered from a recurrent fever for six months. She was diagnosed with dysfunction of blood clotting, hepatic function damage, hepatosplenomegaly and lymphadenopathy accompanied with high titer of EBV and significantly increased NK cell. WES showed that she carried the NFKB1 gene de nove mutation: c.2430 dupA. Its site had not been reported before. Different from previous reports, the mutation was located in the death domain of the protein, which may lead to an early termination of amino acid. Functional experiment showed decreased p50 expression and unstable mRNA. Conclusion:NFKB1 deficiency could be diagnosed by combining clinical and immunological features with genetic phenotypes. We expanded the clinical and genetic phenotypes of this disease.

中图分类号: